"Developing evidence to support product clearance, reimbursement and adoption – an overview"
The Institute for Engineering in Medicine (IEM) is pleased to announce a seminar by Dr. Edwin Hedblom, “Developing evidence to support product clearance, reimbursement and adoption – an overview.”
Health care regulators, payers and clinicians require increasing levels of evidence of clinical and economic value. This presentation will discuss the underling drivers of these requirements and strategies in establishing product value that enable medical technology adoption and growth.
Ed is a clinical pharmacist by training and received his Pharm.D. from the University of Minnesota College of Pharmacy. He has had a diverse career in the managed care, pharmaceutical and medical device industries. He has worked in several fortune 100 companies including United Health Group, Aetna, AstraZeneca, and 3M.
Ed currently leads evidence development strategies and market access for 3M Health Care and is responsible for leading 3M Health Care’s clinical and health economic research world-wide.
In addition to his experience at 3M, Ed has served as Chief Pharmacy Officer for AARP Pharmacy Services, Chief Pharmacy Officer for Aetna US Healthcare and has served as Global Director for Health Economics at AstraZeneca. He has is also active in the Academy for Managed Care Pharmacy (AMCP), International Society for Health Economic Research (ISPOR) and Society for Healthcare Epidemiology of America (SHEA).
He brings a unique perspective on the use of clinical, health economic, quality of life information in the management and delivery of health care as he has acted as both a user and producer of clinical and health economic information. Ed knows first-hand the challenges of conducting and interpreting data to make health technology decisions.
For additional information on Dr. Hedblom’s presentation please contact firstname.lastname@example.org.
Click here for the flyer on this seminar.